Medical Student | Naval Medical University | China
Ms. Zixin Wang is an emerging researcher in the fields of tumor microenvironment biology and cancer immunotherapy, with a growing academic foundation in clinical medicine and surgical sciences. Her research interests are shaped by her training at the Second Military Medical University, where she pursued an undergraduate degree in Clinical Medicine (2021–2026), and her forthcoming academic engagement as a Master’s student in General Surgery at the Shanghai Medical College of Fudan University (2026–2029). Her academic trajectory reflects a strong commitment to translational oncology, integrating clinical insights with mechanistic research to improve therapeutic strategies for cancer patients. A key focus of Ms. Wang’s research is the tumor microenvironment (TME)—a complex cellular ecosystem that plays a decisive role in tumor progression, immune evasion, and treatment response. By studying the interactions between cancer cells, stromal components, and immune infiltrates, she aims to identify factors that influence immunotherapy effectiveness.Ms. Wang’s published work, “Mechanisms, advances, and challenges of immunotherapy in gastric cancer” in Frontiers in Immunology (2025), highlights her expertise in analyzing current and emerging immunotherapeutic modalities, including checkpoint inhibition, CAR-T cell therapy, and tumor vaccine development. Her scholarship examines both the molecular underpinnings and clinical bottlenecks of these therapies, with particular emphasis on the heterogeneity of gastric cancer, resistance pathways, and TME-driven immunosuppression.Through her interdisciplinary approach spanning clinical practice and immune-oncology research, Ms. Wang aims to contribute to the development of more precise, responsive, and personalized cancer treatments. Her evolving body of work positions her as a promising young scientist dedicated to advancing the future of surgical oncology and immunotherapeutic innovation.
Profiles: ORCID
Featured Publications
Wang, Z., & Wang, T. (2025). Mechanisms, advances, and challenges of immunotherapy in gastric cancer. Frontiers in Immunology, 16, Article 1639487.
Ms. Zixin Wang’s work advances the scientific understanding of the tumor microenvironment and improves the design of next-generation immunotherapies for gastric cancer, supporting the development of more precise and effective treatment strategies. Her research contributes to society by enabling earlier, more targeted, and less toxic cancer care, while also informing clinical innovation within the biomedical and healthcare industries. With a vision focused on translational impact, her efforts aim to accelerate global progress in cancer immunotherapy and personalized oncology.